http://www.fpnotebook.com/
Carvedilol
Aka: Carvedilol, Coreg
- See Also
- Beta Blocker
- Beta Blocker Overdose
- Indication
- Stable Congestive Heart Failure (Compensated)
- Mechanism: Third generation Beta Blocker (vasodilatory properties)
- Beta Adrenergic Receptor Antagonist
- Non-selective Beta Blocker
- Vasodilator (alpha antagonist)
- Blunts sympathetic drive
- Preserves some heart function
- Does not affect Blood Glucose
- Dosing: Stable Congestive Heart Failure
- Start: 3.125 mg PO bid with food
- Titrate up by doubling dose every 2 weeks
- Maximum dose
- Weight <85 kg: 25 mg bid
- Weight >85 kg: 50 mg bid
- Conversion from prior Beta Blocker
- No overlap from Metoprolol 50 mg or Atenolol 50 mg
- Start Carvedilol 6.25 mg bid and increase as above
- Overlap from Atenolol 50-150 or Metoprolol 100-200
- Add Carvedilol 3.125 mg bid for 2 weeks
- Raise Carvedilol and lower other Beta Blocker
- Double Carvedilol every two weeks
- Reduce Atenolol or Metoprolol by 50 mg q2 weeks
- When to stop other Beta Blocker
- After 2 weeks on Metoprolol 50 mg or
- After 2 weeks on Atenolol 25 mg
- Follows prior 2 weeks on Atenolol 50 mg
- Reference
- Abraham (2003) Congest Heart Fail 9:251-8
- Efficacy
- Carvedilol used in severe Congestive Heart Failure
- Findings
- Mean Ejection Fraction: 23%
- Studied over 6 months
- Overall mortality reduced (3.2% vs 7.8%)
- Reference
- Packer (1996) N Engl J Med 334:1349-55
- Utah Study of Carvedilol in CHF
- Ejection Fraction improved 20% to 33%